The case also marks an important evolution in the DOJ’s scrutiny of software companies, according to Colette G. Matzzie, a partner with Phillips & Cohen in Washington.
“The government has been focusing on the compliance of these systems with federal regulations up to now,” she said. “But this case shows that DOJ is now looking at the whole web of relationships between these EHR makers and drug companies, doctors, hospitals, and laboratories. This is a very significant step.”
Mattzie represented the whistleblower in a lawsuit against eClinicalWorks, another EHR maker, that led to a $155 million settlement with the government.
Read the entire article, “Opioid Case Spotlights Use of AI for Health-Care Fraud” on Bloomberg Law‘s website.